Skip to content

Insider · CIK 0001882877

Jeetinder Singh Mahal

cooofficer

Files at JSPR (Jasper Therapeutics, Inc.). First filing Dec 12, 2024, latest Dec 12, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $20k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

JSPR: Jasper Therapeutics, Inc.

JSPROct 9, 2026 · close 0.57

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
JSPRsell10b5-1
Jasper Therapeutics, Inc.
$20k
900 shares
-3%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 4, 2025JSPR
Jasper Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+90,000$0.00$090,000Jun 6, 2025
Feb 13, 2025JSPR
Jasper Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+50,000$0.00$050,000Feb 18, 2025
Dec 12, 2024JSPR
Jasper Therapeutics, Inc.
MOption exercise
Voting Common Stock10b5-1
+900$7.10$6,39025,909Dec 12, 2024
Dec 12, 2024JSPR
Jasper Therapeutics, Inc.
SOpen-market sale
Voting Common Stock10b5-1
-900$22.11$20k25,009Dec 12, 2024
Dec 12, 2024JSPR
Jasper Therapeutics, Inc.
MOption exercise
Stock Option (right to buy)derivative10b5-1
+900$0.00$013,772Dec 12, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeetinder Singh Mahal: insider trades and track record | InsiderTell